食管鳞状细胞癌的辅助治疗。

Q3 Medicine

Korean Journal of Thoracic and Cardiovascular Surgery Pub Date : 2020-08-05 DOI:10.5090/kjtcs.2020.53.4.168

Jong-Mu Sun

{"title":"食管鳞状细胞癌的辅助治疗。","authors":"Jong-Mu Sun","doi":"10.5090/kjtcs.2020.53.4.168","DOIUrl":null,"url":null,"abstract":"Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.","PeriodicalId":38678,"journal":{"name":"Korean Journal of Thoracic and Cardiovascular Surgery","volume":"53 4","pages":"168-171"},"PeriodicalIF":0.0000,"publicationDate":"2020-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/16/6d/KJTCV-53-168.PMC7409891.pdf","citationCount":"0","resultStr":"{\"title\":\"Adjuvant Therapy for Esophageal Squamous Cell Carcinoma.\",\"authors\":\"Jong-Mu Sun\",\"doi\":\"10.5090/kjtcs.2020.53.4.168\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.\",\"PeriodicalId\":38678,\"journal\":{\"name\":\"Korean Journal of Thoracic and Cardiovascular Surgery\",\"volume\":\"53 4\",\"pages\":\"168-171\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/16/6d/KJTCV-53-168.PMC7409891.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Korean Journal of Thoracic and Cardiovascular Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5090/kjtcs.2020.53.4.168\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Journal of Thoracic and Cardiovascular Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5090/kjtcs.2020.53.4.168","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

完全切除的食管鳞状细胞癌的辅助治疗在临床实践中应用较少，但在提高食管癌患者的生存率方面发挥了重要作用。本文简要回顾了有关食管鳞状细胞癌辅助治疗的证据和未来的发展方向，特别是免疫治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Adjuvant Therapy for Esophageal Squamous Cell Carcinoma.

Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Korean Journal of Thoracic and Cardiovascular Surgery Medicine-Surgery

自引率

0.00%

发文量

审稿时长

36 weeks